KISR secures patent for virus-resistant surfaces made from solid waste
KUWAIT CITY, March 10: The Kuwait Institute for Scientific Research (KISR) announced that its Environment and Life Sciences Research Center has been granted a patent by the United States Patent and Trademark Office (US 12 219 959 B1) for a project focused on developing surfaces resistant to viruses and bacteria using solid waste.
In a press statement, the institute explained that the invention, developed by Dr. Sultan AlSalem, Dr. Fadhila Al-Salamin, and Professor Dr. Mohammad Sharif Al-Iskandarani, marks a significant advancement in waste management and valorization in Kuwait. The patented surfaces are designed to resist the novel coronavirus (COVID-19) as well as common bacteria that cause infectious diseases.
The research team utilized nano-coating techniques, incorporating a blend of metals such as nickel, silver, and copper. They tested various mixtures using different techniques to create resistant surfaces from pure plastic, plastic waste, and biodegradable plastic.
The invention contributes to improving public health by reducing the spread of viruses and bacteria, thereby lowering the risk of infections, especially in public spaces and healthcare facilities. Additionally, it supports environmental sustainability by repurposing solid plastic waste to manufacture these resistant surfaces, helping reduce waste accumulation.
Furthermore, the invention has economic potential by turning waste into valuable products, creating new economic opportunities that support sustainable development.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Arab Times
7 days ago
- Arab Times
Kuwait's Blood Bank sees strong support with 90,000 donors in 2024: health minister
KUWAIT CITY, May 27: Minister of Health Dr. Ahmad Al-Awadhi on Monday announced that the Kuwait Central Blood Bank (CBB) attracted over 90,000 donors in the past year, who contributed more than 190,000 blood products including platelets, plasma, and red blood cells. Dr. Al-Awadhi made the remarks during a ceremony commemorating the 60th anniversary of the Central Blood Bank, in conjunction with World Blood Donor Day, and a national event honoring donors for their vital contributions. He noted that the CBB also supplied approximately 150,000 blood units in 2024 to support healthcare for cancer and thalassemia patients, as well as those requiring emergency care across hospitals nationwide. Established in 1965, the Central Blood Bank was the region's first integrated national blood transfusion center. Dr. Al-Awadhi highlighted its pioneering role as a launch pad for a comprehensive institutional blood donation system in Kuwait and the wider region. He emphasized the Bank's longstanding commitment to international standards, noting that it was among the first in the region to receive accreditation from the American Association of Blood Banks (AABB) in 1989. The CBB has also earned recognition from the International Society of Blood Transfusion (ISBT) and the College of American Pathologists (CAP). 'These accreditations reflect our commitment to rigorous scientific and quality standards,' Dr. Al-Awadhi said. 'With advanced technologies in place, we've enhanced efficiency in blood utilization and ensured high-quality transfusion services that reduce waste and increase patient readiness.' He added that the Blood Bank and its branches have organized thousands of donation campaigns in recent years, engaging various sectors of society and fostering a national culture of voluntary donation. The minister reaffirmed the government's continued support for the blood donation system through ongoing infrastructure development, laboratory modernization, and training of national medical personnel to ensure sustainability, quality, and efficiency. Also speaking at the event, Dr. Reem Al-Radwan, Director of the Blood Transfusion Services Department at the Ministry of Health, reflected on the Blood Bank's crucial role during key moments in Kuwait's history, including its response during the Iraqi invasion and the COVID-19 pandemic. Dr. Al-Radwan said the CBB continues to organize strategic blood donation campaigns to maintain a safe and sustainable supply for hospitals. She also announced the launch of the Blood Bank's 60th Anniversary Campaign, aimed at reinforcing the life-saving importance of blood donation.
Arab Times
25-05-2025
- Arab Times
Hosting Stockholm Regional Centre enhances Kuwait's environmental leadership: KISR
KUWAIT CITY, May 25: The Kuwait Institute for Scientific Research (KISR) affirmed on Saturday that hosting the Stockholm Convention Regional Centre for Training and Technology Transfer for West Asia underscores Kuwait's leading role in advancing global environmental initiatives and solidifies its status as a key regional hub for chemical and waste risk management. Dr. Mohammad Al-Otaibi, Coordinator of the Regional Centre and a scientific researcher at KISR, told KUNA that the center provides technical and training services to countries across West Asia. It serves as a vital link between three major environmental agreements—most notably the Stockholm Convention—and the member states, offering technical support, technology transfer, regular updates, and assistance in implementing national action plans and submitting periodic reports. Since its inception, the center has conducted numerous regional training workshops, Al-Otaibi noted. It is now preparing to host an expanded workshop in October 2025 at KISR's headquarters. The event will bring together participants from Gulf Cooperation Council (GCC) countries, other West Asian nations, and international experts to address recent updates to the convention, including chemicals such as PFAS, UVA-328, and PCBs, as well as the latest testing and reporting mechanisms. He highlighted that the center recently completed an updated national survey of banned chemicals in Kuwait in coordination with relevant agencies, including the Environment Public Authority, which fully supported the effort. A comprehensive report was submitted to the Stockholm Convention Secretariat. The center is now working on a new inventory of newly added substances to be submitted according to the required timeline. Al-Otaibi outlined the center's strategic work plan for 2024–2027, which is built around eight key areas: organizing advanced training workshops, implementing national research projects, updating national implementation plans (NIP), building a regional chemical database, evaluating new chemicals, and facilitating regional coordination and periodic reporting. He stressed that collaboration with donors and international organizations — such as the Global Environment Facility (GEF) and the United Nations Environment Programme (UNEP) — has strengthened the center's capabilities. These partnerships help facilitate technology transfer, expand regional influence, and enhance Kuwait's environmental commitments while creating valuable opportunities for national capacity-building. Al-Otaibi also emphasized the importance of KISR's participation in the recent Conferences of the Parties to the Basel, Rotterdam, and Stockholm Conventions, held in Geneva from April 28 to May 9, 2025. Kuwait's involvement, he said, showcased the country's environmental efforts and contributed to key decisions, including the addition of new chemicals to the conventions, updates to technical guidelines, and the launch of joint environmental compliance programs. He added that the regional center provides strategic value for Kuwait, not only as a scientific and training hub but also as an essential mechanism for protecting public health and the environment. The center's success, he noted, has been made possible by the support of the Kuwaiti leadership and collaboration with national partners. Additionally, Al-Otaibi said the center plays a critical role in developing national human resources, proposing scientifically validated alternatives to banned substances, and reducing environmental pollution costs—ultimately supporting Kuwait's economy and promoting sustainable development. Kuwait ratified the Stockholm Convention in March 2006. In May 2009, during the Fourth Conference of the Parties in Geneva, KISR was officially approved as the Regional Centre for Training and Technology Transfer for West Asia, making it the first internationally accredited Arab center of its kind. Since its formal launch in 2011, the center has served as a scientific and technical cornerstone for advancing environmental policy and fostering coordinated regional efforts.
Arab Times
24-05-2025
- Arab Times
More than 300 people still die of COVID every week in the US
NEW YORK, May 24: More than five years after COVID-19 first appeared in the United States, hundreds of people continue to die from the virus each week. According to data from the Centers for Disease Control and Prevention (CDC), last month saw an average of about 350 COVID-related deaths per week. While this number remains high, it is declining and is much lower than the peak of 25,974 weekly deaths recorded the week ending January 9, 2021, as well as the high death tolls seen in previous spring months, the CDC data shows. Public health experts told ABC News that although the U.S. is in a better situation than it was a few years ago, COVID still poses a threat, especially to high-risk populations. Dr. Tony Moody, a professor of pediatrics and infectious diseases at Duke University Medical Center, explained that ongoing deaths indicate the virus is still spreading and people continue to catch it. Experts cited several reasons why COVID deaths persist, including low vaccination rates, waning immunity, and insufficient access to treatments. During the 2024-25 season, only 23% of adults aged 18 and older had received the updated COVID-19 vaccine as of the week ending April 26, according to CDC data. Among children, just 13% were vaccinated with the updated shot during the same period. Dr. Gregory Poland, a vaccinologist and president of the Atria Research Institute, suggested that the low vaccine uptake contributes to the ongoing deaths. Additionally, some vaccinated individuals may not develop strong immunity. Poland noted, 'Some people may be genetically predisposed to respond poorly to vaccines. More commonly, immunocompromised individuals cannot mount an adequate immune response.' He added that vaccine immunity decreases over time, which raises the risk of infection. This is why the current guidance recommends two doses of the updated vaccine six months apart for those aged 65 and older. 'Another factor in COVID deaths is older age, where immune function declines — a process called immunosenescence,' Poland explained. 'In addition, older adults often have accumulated other health conditions that increase risk.' CDC data shows that people aged 75 and older currently face the highest COVID death rate, at 4.66 deaths per 100,000. Available COVID treatments include antiviral pills such as molnupiravir (from Merck and Ridgeback Biotherapeutics) and Paxlovid (from Pfizer). Both must be started within five days of symptom onset and are taken twice daily for five days—molnupiravir as four pills each time and Paxlovid as three. There is also remdesivir, an intravenous drug that must be administered within seven days of symptom onset. Dr. Moody pointed out, 'I think we aren't fully utilizing the treatments available. Many patients who receive these medications experience significant benefits, and clinical trials support their effectiveness.' He added that some patients delay seeking medical care until symptoms worsen, or do not get tested for COVID at all, which means they miss out on timely treatment. 'There are definitely people who are infected but remain undiagnosed and untreated,' Moody said. He emphasized that regular testing isn't necessary for everyone, but high-risk individuals should test more frequently.
